Friday, April 10, 2020

BMW and Great Wall pushes electric car production plan in China

Featured

Russia begins clinical trials of Coronavirus drugs

The press service of the Russian Federal Biomedical Agency announced that clinical trials based on mefloquine, hydroxychloroquine and caledavir...

Coronavirus: UK Premier transferred to intensive care

British Prime Minister Boris Johnson was transferred to intensive care tonight at St Thomas hospital after his condition deteriorated...

New York: 102,863 Coronavirus cases, escalating daily

New York Governor Andrew Como has announced that the number of Coronavirus cases in the state has risen to...
Zain Zubair
Zain Zubair
Zain Zubair is a staff writer for World News Observer. He is studying ACCA in Pakistan. Besides Accountancy and writing pieces, he loves cooking and nature photography. Zain has attended various modern journalism workshops. Contact: [email protected]

Automaker BMW and Great Wall push their plan for the production of electric cars especially in China. In the long term, around 160,000 electric vehicles from the BMW Mini and from Great Wall are to roll off the production line in a joint factory per year, as BMW announced on Friday at the start of construction in the city of Zhangjiagang near Shanghai.

The work itself is to be built by 2022. This is usually followed by a multi-year period for plant construction, pre-series production and start-up phase. The project, agreed in 2018, initially encountered obstacles in the approval process.

With the plant, BMW is strengthening its presence in China, where the government is pushing the industry to build electric cars. For electric minis, Zhangjiagang becomes Oxford’s second manufacturing facility.

The German company already holds a majority stake in China in a joint venture with the carmaker Brilliance, which produces vehicles of the BMW brand.

Half of the two partners are involved in the Great Wall joint venture called Spotlight Automotive Limited. They want to invest the equivalent of 650 million euros in the plant, which should employ 3,000 people.

Meanwhile, the weakening automaker Audi cuts investment in view of its austerity. For the next five years until 2024, the Volkswagen subsidiary wants to put together around 37 billion euros in research and development and capital investment, as the company announced on Friday in Ingolstadt, a city of Bavaria.

In the last five-year plan from 2019 to 2023 Audi had estimated 40 billion euros. The current planning reflects a better investment and cost discipline, it said.

Audi is currently significantly reducing its capacity in the under-utilized German plants Ingolstadt and Neckarsulm. 9500 jobs are to be eliminated without redundancies, in return Audi wants to create 2000 new jobs in other areas.

However, the company wants to invest more money in certain areas. Of the planned investments until 2024, a large part is intended to flow into electric drives and models.

“With around 12 billion euros, we will spend more than ever before for electromobility by 2024”, said Audi CFO Alexander Seitz, who will move to core brand VW Passenger Cars on 1 March in the same capacity.

The investment plans are part of the five-year budget round of the VW Group, which was presented two weeks ago. The Wolfsburg want across all brands group-wide by 2024 around 150 billion euros in investment, research and development. Of this amount, around 33 billion will be available for electric mobility alone.

Read also: Electric scooter takes on the US cities, 38.5 million trips in a year

Zain Zubair
Zain Zubair
Zain Zubair is a staff writer for World News Observer. He is studying ACCA in Pakistan. Besides Accountancy and writing pieces, he loves cooking and nature photography. Zain has attended various modern journalism workshops. Contact: [email protected]

Latest News

ExxonMobil Reduces 2020 Capex by 30%, Cash Opex by 15%; Maintains Long-Term Outlook

ExxonMobil said today it is reducing its 2020 capital spending by 30 percent and lowering cash operating expenses by...

Russia begins clinical trials of Coronavirus drugs

The press service of the Russian Federal Biomedical Agency announced that clinical trials based on mefloquine, hydroxychloroquine and caledavir drugs for the treatment of...

Coronavirus: UK Premier transferred to intensive care

British Prime Minister Boris Johnson was transferred to intensive care tonight at St Thomas hospital after his condition deteriorated following his coronavirus hospitalization. This...

New York: 102,863 Coronavirus cases, escalating daily

New York Governor Andrew Como has announced that the number of Coronavirus cases in the state has risen to 102,863. He said: "New York is...

Pakistan: ABAD terms Construction Incentives as historic

Chairman Association of Builders and Developers of Pakistan (ABAD) Mohsin Sheikhani has termed the incentives announced by Prime Minister Imran Khan as a historic...

Related News